Teladoc Health (TDOC) Current Deferred Revenue (2019 - 2026)

Teladoc Health has disclosed Current Deferred Revenue across 8 years of filings, most recently posting $70.5 million for Q2 2026.

• In Q2 2026, Current Deferred Revenue fell 17.46% year-over-year to $70.5 million; the TTM figure through Jun 2026 stood at $70.5 million (down 17.46% YoY), while the FY2025 annual figure was $71.4 million, down 19.8% from the prior year.
• Current Deferred Revenue came in at $70.5 million for Q2 2026 at Teladoc Health, down from $76.1 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $121.6 million in Q2 2023 to a low of $70.5 million in Q2 2026.
• Average Current Deferred Revenue over 5 years is $98.0 million, with a median of $103.0 million recorded in 2024.
• Year-over-year, Current Deferred Revenue surged 50.55% in 2022 and declined 27.58% in 2025.
• Over 5 years, Current Deferred Revenue stood at $113.8 million in 2022, then declined by 3.96% to $109.3 million in 2023, then declined by 18.48% to $89.1 million in 2024, then dropped by 19.8% to $71.4 million in 2025, then slipped by 1.35% to $70.5 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $70.5 million in Q2 2026, $76.1 million in Q1 2026, and $71.4 million in Q4 2025.